Why You Should Attend:
The global regulation of medical devices is rapidly evolving, integrating the regulatory systems of the most advanced medical device regulations. To be able to achieve sustainability and to remain competitive in global medical device markets, it is necessary to streamline the regulatory process what would help to reduce or eliminate differences between countries, gain regulatory compliance at a reduced cost, allow intended users and other stakeholders earlier access to advanced and innovative medical device products for treatments and improve healthcare in a safe and effective way during post-marketing through surveillance program.
This webinar is intended to walk you through how to streamline the regulatory process in a systematic manner in the US, EU and Canada. This 3-hr training will discuss medical device regulations and law in the US, Europe and Canada. It is designed to help the audience with their global compliance and regulatory intelligence. This seminar is a “How To Guide” intended to streamline the decision-making process in a systematic manner.
Areas Covered in the seminar:
Who will Benefit:
This webinar will be valuable for anyone in global medical device industry including, but not limited to, those working on drugs, biologics and in vitro diagnostic devices. It is particularly useful for those who are engaged in the design and development of medical devices, combinations products (e.g., drug and devices, biologics and devices), and in vitro diagnostic devices including companion medical products. This webinar is a must for those who are directly or indirectly involved in handling regulatory submissions to the FDA, EU and Health Canada.
The following employees who will benefit include:
Dr. David Lim, obtained his Ph.D. in biological sciences at the University of Missouri-Columbia in 1993. Since then, Dr. Lim has held various positions at Duke, US National Laboratories, Intrexon Corporation, Terumo and Center for Devices and Radiological Health (CDRH) at US Food and Drug Administration (FDA). Currently, Dr. Lim is Senior Vice President of Scientific and Regulatory Affairs at Aquavit Pharmaceuticals, Inc., in New York. Prior to Aquavit Pharmaceuticals, Dr. Lim served as Director of Regulatory Affairs at EraGen Biosciences, Inc., A Luminex Company in Madison, WI. Dr. Lim is a certified professional for regulatory affairs (RAC) and also is a certified quality auditor (CQA) by the American Society for Quality (ASQ). Dr. Lim is an auditor, consultant and instructor for global matters pertaining to compliance, regulatory affairs, quality and clinical affairs.
Our refund policy is governed by individual products and services refund policy mentioned against each of offerings. However in absence of specific refund policy of an offering below refund policy will be effective.
Registrants may cancel up to two working days prior to the course start date and will receive a letter of credit to be used towards a future course up to one year from date of issuance. ComplianceOnline would process/provide refund if the Live Webinar has been cancelled. The attendee could choose between the recorded version of the webinar or refund for any cancelled webinar. Refunds will not be given to participants who do not show up for the webinar. On-Demand Recordings can be requested in exchange. Webinar may be cancelled due to lack of enrolment or unavoidable factors. Registrants will be notified 24hours in advance if a cancellation occurs. Substitutions can happen any time. On-Demand Recording purchases will not be refunded as it is available for immediate streaming. However if you are not able to view the webinar or you have any concern about the content of the webinar please contact us at below email or by call mentioning your feedback for resolution of the matter. We respect feedback/opinions of our customers which enables us to improve our products and services. To contact us please email [email protected] call +1-888-717-2436 (Toll Free).
PAYMENT METHOD: 100% Secure Transaction